Hennessy Advisors Inc Eli Lilly & CO Transaction History

Hennessy Advisors Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 08, 2019	SELL	$111.31 - $131.02 $7.68 Million - $9.04 Million	-69,000 Closed	0 $0
Q4 2018 Jan 14, 2019	SELL	$105.9 - $118.64 $264,750 - $296,600	-2,500 Reduced 3.5%	69,000 $7.99 Million
Q1 2018 May 02, 2018	BUY	$74.21 - $87.6 $5.31 Million - $6.26 Million	71,500 New	71,500 $5.53 Million

3,872

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Hennessy Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Hennessy Advisors Inc with notifications on news.